Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Spheryx
AddedFeb 15, 2024
UpdatedJun 18, 2026
Spheryx

Spheryx

Seed

Spheryx: NY-based provider of holographic characterization services and instruments for colloidal suspensions.

HQ
New York City, NY, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Spheryx, founded in New York, specializes in providing advanced services and instruments for the total holographic characterization of colloidal suspensions. Their core mission is to revolutionize particle characterization through innovative technology, enabling more accurate and comprehensive analysis of colloidal particles. Spheryx's primary product, Total Holographic Characterization (THC), offers significant advantages in detecting heterogeneous protein aggregates, making it particularly valuable in biopharmaceutical applications.

Notable affiliations include praise from The Journal of Pharmaceutical Sciences, highlighting THC's superiority over traditional methods like Flow Imaging (FI) and Resonant Mass Measurement (RMM). Spheryx's key achievements include significant advancements in the detection of sub-visible protein particles, impacting the quality control processes in the pharmaceutical industry. Overall, Spheryx has made a substantial impact by enhancing the precision and reliability of particle characterization, contributing to improved product safety and efficacy.

Spheryx - Similar Companies

Spheringenics logo

Spheringenics

Halo Labs logo

Halo Labs

halolabs.com

Phasiq logo

Phasiq

SpheroFill logo

SpheroFill

spherofill.net

Spyryx Biosciences logo

Spyryx Biosciences

SphynKx Therapeutics logo

SphynKx Therapeutics

Xsphera Biosciences logo

Xsphera Biosciences

Perosphere Technologies logo

Perosphere Technologies

perospheretech.com

Spectradyne logo

Spectradyne

Silver logo

Silver

H2Optx logo

H2Optx

XRpro logo

XRpro

Sapphiros logo

Sapphiros

sapphiros.com

BioHybrid Solutions logo

BioHybrid Solutions

Aurora Spectral Technologies logo

Aurora Spectral Technologies

Spheryx - Quick Facts

Who are Spheryx's competitors?

Companies similar to Spheryx include Spheringenics, Halo Labs, Phasiq and SpheroFill.

When was Spheryx founded?

Spheryx was founded in 2014.

Where is Spheryx's headquarters located?

Spheryx's headquarters is located in New York City, NY, US.

When was Spheryx's last funding round?

Spheryx's most recent funding round was for $675k (USD) in April 2023.

How much has Spheryx raised to-date?

As of Apr 14, 2023, Spheryx has raised a total of $2.7M (USD).

How many employees does Spheryx have?

Spheryx has 13 employees as of Feb 5, 2024.

Spheryx - Classification

Industry
  • Hardware
Technology
  • Analytics
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Instruments
  • Services
Tags
  • Biotech
  • Data
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software